HUS2000016I1 - Drospirenont és fogamzásgátló kitet tartalmazó gyógyászati készítmény - Google Patents

Drospirenont és fogamzásgátló kitet tartalmazó gyógyászati készítmény

Info

Publication number
HUS2000016I1
HUS2000016I1 HUS2000016C HUS2000016C HUS2000016I1 HU S2000016 I1 HUS2000016 I1 HU S2000016I1 HU S2000016 C HUS2000016 C HU S2000016C HU S2000016 C HUS2000016 C HU S2000016C HU S2000016 I1 HUS2000016 I1 HU S2000016I1
Authority
HU
Hungary
Prior art keywords
drospirenone
pharmaceutical composition
contraceptive kit
contraceptive
kit
Prior art date
Application number
HUS2000016C
Other languages
English (en)
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42671710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS2000016(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of HUS2000016I1 publication Critical patent/HUS2000016I1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HUS2000016C 2010-06-29 2020-06-11 Drospirenont és fogamzásgátló kitet tartalmazó gyógyászati készítmény HUS2000016I1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
EP11727985.1A EP2588114B1 (en) 2010-06-29 2011-06-28 Pharmaceutical composition comprising drospirenone and contraceptive kit

Publications (1)

Publication Number Publication Date
HUS2000016I1 true HUS2000016I1 (hu) 2020-07-28

Family

ID=42671710

Family Applications (3)

Application Number Title Priority Date Filing Date
HUE19209672A HUE058176T2 (hu) 2010-06-29 2011-06-28 Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra
HUS2000016C HUS2000016I1 (hu) 2010-06-29 2020-06-11 Drospirenont és fogamzásgátló kitet tartalmazó gyógyászati készítmény
HUS2200018C HUS2200018I1 (hu) 2010-06-29 2022-05-10 Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE19209672A HUE058176T2 (hu) 2010-06-29 2011-06-28 Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUS2200018C HUS2200018I1 (hu) 2010-06-29 2022-05-10 Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra

Country Status (23)

Country Link
US (6) US11452695B2 (hu)
EP (3) EP2588114B1 (hu)
JP (1) JP5810159B2 (hu)
KR (3) KR20130048227A (hu)
AR (1) AR081670A1 (hu)
BR (1) BR112012033391B1 (hu)
CA (3) CA3061421C (hu)
CY (2) CY1122544T1 (hu)
DK (1) DK3632448T3 (hu)
EA (1) EA028680B1 (hu)
ES (1) ES2908657T3 (hu)
FR (2) FR20C1020I1 (hu)
HR (1) HRP20220332T1 (hu)
HU (3) HUE058176T2 (hu)
LT (2) LT3632448T (hu)
NO (1) NO2020015I1 (hu)
NZ (1) NZ605176A (hu)
PE (2) PE20161410A1 (hu)
PL (2) PL3632448T3 (hu)
PT (1) PT3632448T (hu)
RS (2) RS59826B1 (hu)
SI (2) SI3632448T1 (hu)
WO (1) WO2012000981A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
PL3310346T3 (pl) 2015-06-18 2021-10-25 Estetra Sprl Dyspergowalna w ustach tabletka zawierająca estetrol
ES2877186T3 (es) 2015-06-18 2021-11-16 Estetra Sprl Comprimido orodispersable que contiene estetrol
US11147771B2 (en) 2015-06-18 2021-10-19 Estetra Sprl Orodispersible dosage unit containing an estetrol component
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
FI3313408T3 (fi) * 2015-06-23 2024-01-25 Laboratorios Leon Farma Sa Drospirenonipohjainen ehkäisyvalmiste ylipainoiselle naispotilaalle
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
WO2023165988A1 (en) 2022-03-01 2023-09-07 Chemo Research, S.L. Chewable oral contraceptive

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
EP0461930B1 (en) 1990-06-15 1995-09-13 Merck & Co. Inc. A crystallization method to improve crystal structure and size
GB2256648B (en) 1991-05-29 1995-08-30 Colorcon Ltd Wax polish composition
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
ATE429231T1 (de) 1999-08-31 2009-05-15 Bayer Schering Pharma Ag Pharmazeutische kombination von ethinylestradiol und drospirenon als empfängnisverhütendes mittel
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
BR0107683A (pt) 2000-01-18 2002-11-12 Schering Ag Drospirenona para terapia de reposição de hormÈnio
US20040087563A1 (en) 2002-11-05 2004-05-06 Siegfried Mayerhofer Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins
US7786101B2 (en) 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en) 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
PL1748756T3 (pl) 2004-03-10 2009-10-30 Bayer Schering Pharma Ag Kompozycje zawierające molekularnie zdyspergowany drospirenon
MY151322A (en) 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1773344A1 (en) 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
EP1625849A1 (en) 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
US20060293295A1 (en) 2005-05-13 2006-12-28 Kai Strothmann Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate
US8475838B2 (en) 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
TW200727920A (en) 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
DK1746101T4 (da) 2005-07-21 2014-08-11 Bayer Pharma AG Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner
CN101489563A (zh) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
EP2063870A2 (en) 2006-09-16 2009-06-03 Bayer Schering Pharma Aktiengesellschaft Oral modified release formulations
AR066166A1 (es) 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
JP2011511816A (ja) 2008-02-13 2011-04-14 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化効果を有する薬物送達システム
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

Also Published As

Publication number Publication date
EP2588114B1 (en) 2019-12-25
US20230372248A1 (en) 2023-11-23
US11478487B1 (en) 2022-10-25
CA3061421A1 (en) 2012-01-05
EP3632448A1 (en) 2020-04-08
JP5810159B2 (ja) 2015-11-11
EP2588114A1 (en) 2013-05-08
CA3003062A1 (en) 2012-01-05
EA201291372A1 (ru) 2013-06-28
LTPA2022513I1 (hu) 2022-07-11
EA028680B1 (ru) 2017-12-29
PL3632448T3 (pl) 2022-05-02
WO2012000981A1 (en) 2012-01-05
AR081670A1 (es) 2012-10-10
AU2011273605A1 (en) 2013-01-17
BR112012033391A2 (pt) 2016-11-22
HRP20220332T1 (hr) 2022-05-13
BR112012033391A8 (pt) 2018-04-17
KR102164693B1 (ko) 2020-10-13
FR20C1020I1 (fr) 2020-08-07
FR22C1031I1 (fr) 2022-09-09
NZ605176A (en) 2015-02-27
HUS2200018I1 (hu) 2022-06-28
AU2011273605B2 (en) 2016-05-26
PE20161410A1 (es) 2017-01-10
US11491113B1 (en) 2022-11-08
US11504334B2 (en) 2022-11-22
CA2803721C (en) 2018-06-12
CA2803721A1 (en) 2012-01-05
EP4056186A1 (en) 2022-09-14
KR20170085604A (ko) 2017-07-24
RS59826B1 (sr) 2020-02-28
RS63027B1 (sr) 2022-04-29
US20230046871A1 (en) 2023-02-16
CA3003062C (en) 2019-12-31
US20220241209A1 (en) 2022-08-04
US11951213B2 (en) 2024-04-09
NO2020015I1 (no) 2020-06-11
PE20130780A1 (es) 2013-07-06
HUE058176T2 (hu) 2022-07-28
US20220339107A1 (en) 2022-10-27
PL2588114T3 (pl) 2020-05-18
EP3632448B1 (en) 2022-01-12
KR20130048227A (ko) 2013-05-09
DK3632448T3 (da) 2022-02-07
US20220339106A1 (en) 2022-10-27
BR112012033391B1 (pt) 2020-02-27
PT3632448T (pt) 2022-03-07
SI2588114T1 (sl) 2020-07-31
SI3632448T1 (sl) 2022-04-29
FR22C1031I2 (fr) 2023-12-22
ES2908657T3 (es) 2022-05-03
US20220339165A1 (en) 2022-10-27
JP2013529665A (ja) 2013-07-22
KR102539030B1 (ko) 2023-05-31
AU2011273605A8 (en) 2016-07-28
KR20210013663A (ko) 2021-02-04
CY1122544T1 (el) 2021-01-27
US11452695B2 (en) 2022-09-27
CY1125061T1 (el) 2023-06-09
LT3632448T (lt) 2022-03-25
CA3061421C (en) 2021-06-01

Similar Documents

Publication Publication Date Title
HUS2000016I1 (hu) Drospirenont és fogamzásgátló kitet tartalmazó gyógyászati készítmény
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL222738A0 (en) Pharmaceutical emulsion composition comprising progestogen
ZA201100605B (en) Micronised progesterone pharmaceutical composition and uses thereof
IL225238B (en) A pharmaceutical composition containing carbatocin and an antioxidant
ZA201301419B (en) Pharmaceutical composition and administrations thereof
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
PT2474522E (pt) Agomelatina e composições farmacêuticas que contêm a mesma
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
GB2480515B (en) Lacquer composition and use thereof
PL2521445T3 (pl) Preparat i jego zastosowanie
ZA201200079B (en) Pharmaceutical compositions and solid forms
PT2474306T (pt) Composição particulada e composição medicinal que a compreende
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
IL217137A0 (en) Medicinal and herbal composition and uses thereof
EP2531180A4 (en) ORAL COMPLEX COMPOSITION WITH PSEUDOEPHEDRINE AND LEVOCETIRIZIN
HUP1000407A2 (en) Ph dependent pulsatile and sustained release pharmaceutical composition
ZA201209743B (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
PL2688418T3 (pl) Bogata w stygmasterol kompozycja fitosterolowa i jej zastosowania
GB201005826D0 (en) New compositions and their use
HK1200328A1 (zh) 含有孕激素的低油藥用乳液組合物
AU2011904096A0 (en) Contraceptive composition and device
AU2011900931A0 (en) Pharmaceutical compositions and use thereof
GB201003741D0 (en) Methods and therapeutic compositions